...
首页> 外文期刊>BMC Immunology >Biological variation of immunological blood biomarkers in healthy individuals and quality goals for biomarker tests
【24h】

Biological variation of immunological blood biomarkers in healthy individuals and quality goals for biomarker tests

机译:健康个体中免疫性血液生物标志物的生物学变异和生物标志物检测的质量目标

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Cytokines, chemokines, adipocytokines, soluble cell receptors, and immune activation markers play an important role in immune responsiveness and can provide prognostic value since they reflect underlying conditions and disease states. This study was undertaken to investigate the components of biological variation for various laboratory tests of blood immunological biomarkers. Estimates of intra-individual coefficient of variation (CVI) and inter-individual coefficient of variation (CVG) were examined for blood immunological biomarkers. Biomarkers with CVI 40% were adiponectin, IL-1ra, leptin, MIP-1β, sCD163, and sIL-2Rα. The biological variations of biomarkers have important monitoring value for longitudinal investigation and are essential for quality specification of tests that are performed in the laboratory. The CVI was relatively small while CVG was comparatively large and mean values of each biomarker vary between subjects. The individuality of biomarkers significantly influences reference interval values. A majority of the biomarkers in this study had strong individuality and the result of each biomarker should be cautiously interpreted if using established reference interval values. Comparison of a patient’s test result with previous ones may be more useful than the usage of conventional reference values.
机译:细胞因子,趋化因子,脂肪细胞因子,可溶性细胞受体和免疫激活标记物在免疫反应中起着重要作用,并且由于它们反映了潜在的病况和疾病状态,因此可以提供预后价值。进行这项研究以调查血液免疫生物学标记物的各种实验室测试的生物学变异的组成部分。检查个体内变异系数(CVI)和个体间变异系数(CVG)的估计值以进行血液免疫生物标记。 CVI 40%的生物标志物是脂联素,IL-1ra,瘦素,MIP-1β,sCD163和sIL-2Rα。生物标志物的生物学变化对于纵向调查具有重要的监测价值,对于实验室中进行的测试质量规范至关重要。 CVI相对较小,而CVG相对较大,每个生物标记物的平均值在受试者之间有所不同。生物标志物的个体性显着影响参考区间值。本研究中的大多数生物标志物具有很强的个性,如果使用确定的参考区间值,则应谨慎解释每种生物标志物的结果。将患者的测试结果与以前的测试结果进行比较可能比使用常规参考值更有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号